Homewood At Plum Creek | |
425 Westminster Avenue, Hanover, Pennsylvania 17331 | |
(717) 637-4166 | |
Name | Homewood At Plum Creek |
---|---|
Location | 425 Westminster Avenue, Hanover, Pennsylvania |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 120 |
Occupancy Rate | 75.75% |
Medicare ID (CCN) | 395898 |
Legal Business Name | Homewood At Hanover, Pa Inc |
Ownership Type | Non Profit - Corporation |
NPI Number | 1245236488 |
Organization Name | HOMEWOOD AT HANOVER, PA INC |
Doing Business As | HOMEWOOD AT PLUM CREEK |
Address | 425 Westminster Ave, Hanover, PA 17331 |
Phone Number | 717-637-4166 |
News Archive
A new review by the International Osteoporosis Foundation Chronic Inflammation and Bone Structure Working Group concludes that early and aggressive treatment of Rheumatoid Arthritis (RA) with biologic drugs, specifically biological disease-modifying anti-rheumatic drugs (DMARDs), may be most effective in halting progressive bone loss in patients with RA.
"In the last of its series called '7 Billion: Conversations That Matter,' Aspen Institute's Global Health and Development on Wednesday hosted a panel of experts based in Africa and the United States on the interconnectedness of gender issues, family planning, population, and access to safe water," GlobalPost's "Global Pulse" blog reports.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
For cancer drug developers, finding an agent that kills tumor cells is only part of the equation. The drug must also spare healthy cells, and - ideally - its effects will be reversible, to cut short any potentially dangerous side effects.
› Verified 5 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
A new review by the International Osteoporosis Foundation Chronic Inflammation and Bone Structure Working Group concludes that early and aggressive treatment of Rheumatoid Arthritis (RA) with biologic drugs, specifically biological disease-modifying anti-rheumatic drugs (DMARDs), may be most effective in halting progressive bone loss in patients with RA.
"In the last of its series called '7 Billion: Conversations That Matter,' Aspen Institute's Global Health and Development on Wednesday hosted a panel of experts based in Africa and the United States on the interconnectedness of gender issues, family planning, population, and access to safe water," GlobalPost's "Global Pulse" blog reports.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
For cancer drug developers, finding an agent that kills tumor cells is only part of the equation. The drug must also spare healthy cells, and - ideally - its effects will be reversible, to cut short any potentially dangerous side effects.
› Verified 5 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 17.12 | 14.46 |
Percentage of long-stay residents who lose too much weight | 7.19 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 48 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.3 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0.93 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0.55 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.19 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 15.89 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 2.8 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 37.68 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 20.88 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 0.68 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
Percentage of short-stay residents who made improvements in function | 78.8 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 98.21 | 82.93 |
News Archive
A new review by the International Osteoporosis Foundation Chronic Inflammation and Bone Structure Working Group concludes that early and aggressive treatment of Rheumatoid Arthritis (RA) with biologic drugs, specifically biological disease-modifying anti-rheumatic drugs (DMARDs), may be most effective in halting progressive bone loss in patients with RA.
"In the last of its series called '7 Billion: Conversations That Matter,' Aspen Institute's Global Health and Development on Wednesday hosted a panel of experts based in Africa and the United States on the interconnectedness of gender issues, family planning, population, and access to safe water," GlobalPost's "Global Pulse" blog reports.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
For cancer drug developers, finding an agent that kills tumor cells is only part of the equation. The drug must also spare healthy cells, and - ideally - its effects will be reversible, to cut short any potentially dangerous side effects.
› Verified 5 days ago
Homewood At Plum Creek Location: 425 Westminster Avenue, Hanover, Pennsylvania 17331 Phone: (717) 637-4166 | |
Spiritrust Lutheran The Village At Utz Terrace Location: 2100 Utz Terrace, Hanover, Pennsylvania 17331 Phone: (717) 637-0633 |